Annual Congress of the European Association of Nuclear Medicine October 13 – 17, 2018 Düsseldorf, Germany
European Journal of Nuclear Medicine and Molecular Imaging (2018) 45 (Suppl 1): S1–S844
DOI: 10.1007/s00259-018-4148-3
EANM‘18
Annual Congress of the
European Association of Nuclear Medicine
October 13 – 17, 2018
Düsseldorf, Germany
Abstracts
European Journal of Nuclear Medicine and
Molecular Imaging (2018) 45 (Suppl 1): S1-S844
10.1007/s00259-018-4148-3
This supplement was not sponsored by outside commercial
interests. It was funded entirely by the association’s own resources.
S1
Eur J Nucl Med Mol Imaging (2018) 45 (Suppl 1): S1–S844
S2
Welcome Message
S3
Programme at a Glance
S4
Oral Sessions
S8
Scientific e-Poster Walks
S233
Scientific e-Posters
S290
e-Poster Walks Technologists
S745
e-Posters Technologists
S780
Authors Index
S785
EANM’19
S840
EANM Focus Meeting 2
S841
ESMIT Level 1: eLearning
S842
ESMIT Level 2: Schools 2019
S843
ESMIT Level 3: High End Courses 2019
S844
S3
Eur J Nucl Med Mol Imaging (2018) 45 (Suppl 1): S1–S844
Dear colleagues, dear friends,
On behalf of the European Association of Nuclear Medicine, it is my great pleasure and honour to welcome you to the 31st Annual EANM’18
Congress in Düsseldorf, Germany.
The EANM meeting is now definitively the world-reference congress in nuclear medicine. In order to maintain our congress at its excellent
level, the meeting will build on the traditions that are highly appreciated by all the attendees, with the expansion of newer features. A
specific educational track, implemented with the collaboration of the European School of Multimodality Imaging and Therapy, will include
up-to-date teaching sessions, enriched pitfalls seminars and Continuous Medical Education interactive sessions. In all these active learning
conferences, attendees will have the possibility to enhance their knowledge of multimodality imaging. A careful evaluation procedure relating to the speakers will be implemented in order to gain feedback and ensure that future interactive sessions continue to enjoy a positive
response. With similar pedagogic intent, numerous multidisciplinary joint symposia, organised by several EANM Committees in collaboration with our sister societies, will offer an integrative approach to various topics relevant to the state of the art of our discipline. I would
like to take this opportunity to make a special appeal to young specialists, who will probably benefit most from the academic sessions. You
represent the future of our discipline and it is you who should begin to shape yourself for a brighter tomorrow in our community!
Of course, all this will not reduce the predominant role of our congress, namely to deliver oral and electronic-poster presentations on the
latest achievements in clinical nuclear medicine, science and technology. On the contrary, the oral sessions will be enriched. Rapid Fire
sessions will draw attention to the highly rated abstracts in specific comprehensive topics, with a panel of top-level presentations followed
by extensive discussions; this will provide attendees with an integrated and coherent view on a wide variety of topics. Furthermore, the
concept of featured oral sessions in which an invited speaker places the presentations into a broader perspective will be generalised to all
the other oral presentations. The now well-established tracks M2M – Molecule to Man (basic and translational science) and Do.MoRe (radionuclide therapy and dosimetry) promise to promote high-quality research through interaction between basic and translational clinical
scientists and to present the latest achievements and developments in the fields of clinical molecular imaging and nuclear medicine therapy. During plenary lectures, distinguished speakers will address the state of the art and new developments in clinical and allied sciences,
covering a broad range of topics with the goal of fostering the provision of the best possible care for our patients. In particular, it is a pleasure
and an honour for me to announce the contribution to our congress of Prof. Bernard L. Feringa, from Groningen, the Netherlands, Nobel
Prize in Chemistry 2016, with a lecture on the “Fascinating World of Molecules”.
At the end of the meeting, the traditional Highlights lecture will provide a broad overview of the science presented at EANM’18. I am
delighted that two young but very motivated and highly respected members of our European Nuclear Medicine community, Prof. Ken
Hermann from Essen, Germany, and Dr. Fijs van Leeuwen from Leiden, the Netherlands, have agreed to take on this task.
For all these reasons, I cordially invite you to EANM’18 to actively participate in our 31st Annual Congress, to meet and interact with friends
and colleagues from all over the world, to discuss science, to learn about the exciting developments in nuclear medicine, to break away
from the daily routine and to enjoy everything that the city of Düsseldorf has to offer.
Francesco Giammarile,
EANM Congress Chair 2017-2019
Eur J Nucl Med Mol Imaging (2018) 45 (Suppl 1): S1–S844
S4
Saturday, October 13, 2018
Plenary Hall
Meeting Room 26
Hall 1
09:00 09:30
09:30 10:00
Hall 2
Hall 3
Hall X
Hall Y
Hall 28
PreSymposium 1
PreSymposium 2
PreSymposium 3
PreSymposium 4
PreSymposium 5
Radiopharmacy/
Drug Development
Clinical Trial
Regulations
10:00 10:30
10:30 11:00
11:00 11:30
Bone & Joint /
Oncology / GEMO
Nuclear Medicine
Management of
Bone Metastases in
the Era of Targeted
Treatments
Translational
Molecular Imaging &
Therapy
The Role of Molecular
Imaging in Radiation
Oncology
Physics / AAPM
Radiomics Image Derived
Parameters in
Multimodality
Imaging
09:00 09:30
09:30 10:00
Neuroimaging /
INMiND
Imaging
Neuroinflammation in
Neurodegeneration
10:00 10:30
10:30 11:00
11:00 11:30
EANM
Advisory
Council
Meeting
11:30 12:00
11:30 12:00
12:00 12:30
12:00 12:30
12:30 13:00
12:30 13:00
13:00 13:30
PreSymposium 6
13:30 14:00
Cardiovascular /
Inflammation &
Infection / ASNC
Recent Imaging
Guidelines on
Myocardial
Amyloidosis,
Sarcoidosis and
Large Vessel
Vasculitis
EANM
Delegates
Assembly
14:00 14:30
14:30 15:00
15:00 15:30
PreSymposium 7
Oncology / Physics
Radiomics, AI and
Machine Learning in
Hybrid Imaging
PreSymposium 8
Oncology / Physics
AlphaEndoradiotherapy in
Solid Tumours
PreSymposium 9
Thyroid / Dosimetry
Dosimetry in
Thyroid Cancer
13:00 13:30
PreSymposium 10
13:30 14:00
Drug Development /
Neuroimaging
Towards New
Radiopharmaceuticals
for Psychiatry
14:00 14:30
14:30 15:00
15:00 15:30
15:30 16:00
15:30 16:00
16:00 16:30
16:00 16:30
16:30 17:00
16:30 17:00
EANM
Members
Assembly
17:00 17:30
17:00 17:30
17:30 18:00
17:30 18:00
18:00 18:30
18:00 18:30
19:30 20:30
19:30 20:30
EANM Opening
Ceremony
Sunday, October 14, 2018
Plenary Hall
08:00 08:30
08:30 09:00
Hall 2
Hall 3
Hall 5
Hall X
Hall Y
Hall 1
Hall 4
Hall 6
Hall 28
Hall A
101
102
103
104
105
106
107
108
110
111
CME 1
Joint
Symposium 1
Joint
Symposium 2
Technologists‘
Opening
M2 (...truncated)
